Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-07-23 Sale | 2024-07-25 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 23,625 | $3.1674 | $74,830 | 118,693 (Direct) | View |
2024-07-19 Sale | 2024-07-23 4:05 pm | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 14,062 | $3.1009 | $43,605 | 142,318 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-11-17 Option Award | 2023-11-21 4:22 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 150,750 | $0 | 156,380 (Direct) | View |
2023-09-07 Exercise | 2023-09-08 4:15 pm | N/A 2023-09-26 | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 5,630 | $0 | 5,630 (Direct) | View |
2023-09-07 Exercise | 2023-09-08 4:15 pm | N/A N/A | Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman | 5,630 | $0.79 | 5,630 (Direct) | View |
2023-07-18 Disposition | 2023-07-20 4:17 pm | N/A 2023-09-26 | Sagimet Biosciences Inc. | SGMT | Kemble George Director | 1,004,069 | $0 | 1,004,069 (Direct) | View |
2023-07-18 Option Award | 2023-07-20 4:17 pm | N/A 2023-09-26 | Sagimet Biosciences Inc. | SGMT | Kemble George Director | 1,004,069 | $0 | 1,004,069 (Direct) | View |
Ownership | 2023-07-13 9:03 pm | N/A 2023-09-26 | Sagimet Biosciences Inc. | SGMT | Kemble George Director | 0 | $0 | 1,004,069 (Direct) | View |